Sleep apnoea and quality of life in growth hormone (GH)-deficient adults before and after 6 months of GH replacement therapy

Clinical Endocrinology

Volumn 65, Issue 1, 2006, Pages 98-105

  Peker, Y ^a,b   Svensson, J ^b   Hedner, J ^b   Grote, L ^b   Johannsson, G ^b  

^a SKARABORG HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ADULT; AGED; ALERTNESS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPWORTH SLEEPINESS SCALE; FEMALE; FUNCTIONAL OUTCOME OF SLEEP QUESTIONNAIRE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; MALE; MINOR SYMPTOM EVALUATION PROFILE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; REM SLEEP; SCORING SYSTEM; SHORT FORM 36; SLEEP APNEA SYNDROME; SLEEP TIME; SLOW WAVE SLEEP; TREATMENT OUTCOME; WELLBEING;

ADULT; CHI-SQUARE DISTRIBUTION; FEMALE; HEALTH STATUS INDICATORS; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; PROSPECTIVE STUDIES; QUALITY OF LIFE; SICKNESS IMPACT PROFILE; SLEEP APNEA SYNDROMES;

EID: 33745283630     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02555.x     Document Type: Article

References (38)

1. Quabbe H.J. Schilling E. Helge H. ( 1966) Pattern of growth hormone secretion during a 24-hour fast in normal adults. Journal of Clinical Endocrinology and Metabolism, 26, 1173 1177.
2. Holl R.W. Hartman M.L. Veldhuis J.D. Taylor W.M. Thorner M.O. ( 1991) Thirty-second sampling of plasma growth hormone in man: correlation with sleep stages. Journal of Clinical Endocrinology and Metabolism, 72, 854 861.
3. Van Cauter E. Kerkhofs M. Caufriez A. van Onderbergen A. Thorner M.O. Copinschi G. ( 1992) A quantitative estimation of growth hormone secretion in normal man: reproducibility and relation to sleep and time of day. Journal of Clinical Endocrinology and Metabolism, 74, 1441 1450.
4. Saini J. Krieger J. Brandenberger G. Wittersheim G. Simon C. Follenius M. ( 1993) Continuous positive airway pressure treatment. Effects on growth hormone, insulin and glucose profiles in obstructive sleep apnea patients. Hormone and Metabolic Research, 25, 375 381.
5. Goldstein S.J. Wu R.H. Thorpy M.J. Shprintzen R.J. Marion R.E. Saenger P. ( 1987) Reversibility of deficient sleep entrained growth hormone secretion in a boy with achondroplasia and obstructive sleep apnea. Acta Endocrinologica, 116, 95 101.
6. Mendelson W.B. Slater S. Gold P. Gillin J.C. ( 1980) The effect of growth hormone administration on human sleep: a dose-response study. Biological Psychiatry, 15, 613 618.
7. Astrom C. Pedersen S.A. Lindholm J. ( 1990) The influence of growth hormone on sleep in adults with growth hormone deficiency. Clinical Endocrinology, 33, 495 500.
8. Schneider H.J. Oertel. H. Murck H. Pollmächer T. Stalla G.K. Steiger A. ( 2005) Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement. Psychoneuroendocrinology, 30, 29 37.
9. Grunstein R.R. Ho K.Y. Sullivan C.E. ( 1991) Sleep apnea in acromegaly. Annals of Internal Medicine, 115, 527 532.
10. Grunstein R.R. Ho K.K. Sullivan C.E. ( 1994) Effect of octreotide, a somatostatin analog, on sleep apnea in patients with acromegaly. Annals of Internal Medicine, 121, 478 483.
11. Nolte W. Radisch C. Rodenbeck A. Wiltfang J. Hufner M. ( 2002) Polysomnographic findings in five adult patients with pituitary insufficiency before and after cessation of human growth hormone replacement therapy. Clinical Endocrinology, 56, 805 810.
12. Wallymahmed M.E. Foy P. MacFarlane I.A. ( 1999) The quality of life of adults with growth hormone deficiency: comparison with diabetic patients and control subjects. Clinical Endocrinology, 51, 333 338.
13. Svensson J. Mattsson A. Rosen T. Wiren L. Johannsson G. Bengtsson B.-Å. Haggstrom M.K. the Swedish KIMS National Board ( 2004) Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption. Growth Hormone and IGF Research, 14, 207 215.
14. Johannsson G. Bjarnason R. Bramnert M. Carlsson L.M. Degerblad M. Manhem P. Rosen T. Thoren M. Bengtsson B.-Å. ( 1996) The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender. Journal of Clinical Endocrinology and Metabolism, 8, 1575 1581.
15. Rajala R. Partinen M. Sane T. Pelkonen R. Huikuri K. Seppalainen A.M. ( 1991) Obstructive sleep apnoea syndrome in morbidly obese patients. Journal of Internal Medicine, 230, 125 129.
16. Johannsson G. Rosén T. Bengtsson B.-Å. ( 1997) Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults. Clinical Endocrinology, 47, 571 581.
17. American Academy of Sleep Medicine Task Force ( 1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine Task Force. Sleep, 22, 667 689.
18. Dahlof C. Dimenas E. Olofsson B. ( 1989) Documentation of an instrument for assessment of subjective CNS-related symptoms during cardiovascular pharmacotherapy. Cardiovascular Drugs and Therapy, 3, 919 927.
19. Aitken R.C. ( 1969) Measurement of feelings using visual analogue scales. Proceedings of the Royal Society of Medicine, 62, 989 993.
20. Weaver T.E. Laizner A.M. Evans L.K. Maislin G. Chugh D.K. Lyon K. Smith P.L. Schwartz A.R. Redline S. Pack A.I. Dinges D.F. ( 1997) An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep, 20, 835 843.
21. Ware J.E. Jr. Sherbourne C.D. ( 1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30, 473 483.
22. Johns M.W. ( 1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep, 14, 540 545.
23. Rosén T. Bengtsson B.-Å. ( 1990) Premature mortality due to cardiovascular diseases in hypopituitarism. Lancet, 336, 285 288.
24. Markussis V. Beshyah S. Fisher C. Sharp P. Nicolaides A. Johnston D. ( 1992) Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet, 340, 1188 1192.
25. Bülow B. Hagmar L. Mikoczy Z. Nordström C. Erfurth E. ( 1997) Increased cerebrovascular mortality in patients with hypopituitarism. Clinical Endocrinology, 46, 75 81.
26. Tomlinson J. Holden N. Hills R. Wheatley K. Clayton R. Bates A. Sheppard M. Stewart P. ( 2001) Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet, 357, 425 431.
27. Svensson J. Bengtsson B.-Å. Rosén T. Odén A. Johannsson G. ( 2004) Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy. Journal of Clinical Endocrinology and Metabolism, 89, 3306 3312.
28. Peker Y. Hedner J. Norum J. Kraiczi H. Carlson J. ( 2002) Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. American Journal of Respiratory and Critical Care Medicine, 166, 159 165.
29. Kraiczi H. Caidahl K. Samuelsson A. Peker Y. Hedner J. ( 2001) Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea-induced hypoxemia during sleep. Chest, 119, 1085 1091.
30. Carlson J. Hedner J. Elam M. Ejnell H. Sellgren J. Wallin B.G. ( 1993) Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest, 103, 1763 1768.
31. Carlson J. Rangemark C. Hedner J. ( 1996) Attenuated endothelium- dependent vascular relaxation in patients with sleep apnea. Journal of Hypertension, 14, 577 584.
32. Kraiczi H. Hedner J. Peker Y. Carlson J. ( 2000) Increased vasoconstrictor sensitivity in obstructive sleep apnea. Journal of Applied Physiology, 89, 493 498.
33. Evans L.M. Davies J.S. Goodfellow J. Rees J.A. Scanlon M.F. ( 1999) Endothelial dysfunction in hypopituitary adults with growth hormone deficiency. Clinical Endocrinology, 50, 457 464.
34. Sverrisdottir Y.B. Elam M. Herlitz H. Bengtsson B.-Å. Johannsson G. 1998) Intense sympathetic nerve activity in adults with hypopituitarism and untreated growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 83, 1881 1885.
35. Svensson J. Sunnerhagen K. Johannson G. ( 2003) Five years of growth hormone replacement therapy in adults: age- and gender-related changes in isometric and isokinetic muscle strength. Journal of Clinical Endocrinology and Metabolism, 88, 2061 2069.
36. Johannsson G. Sunnerhagen K.S. Svensson J. ( 2004) Baseline characteristics and the effects of two years of growth hormone (GH) replacement therapy in adults with GH deficiency previously treated for Cushing's disease. Clinical Endocrinology, 60, 550 559.
37. Koranyi J. Svensson J. Götherström G. Sunnerhagen K.S. Bengtsson B.-Å. Johannsson G. ( 2001) Baseline characteristics and the effects of five years of growth hormone (GH) replacement therapy in adults with GH deficiency of childhood or adulthood onset; a comparative, prospective study. Journal of Clinical Endocrinology and Metabolism, 86, 4693 4699.
38. Johansson J.-O. Larsson G. Andersson M. Elmgren A. Hynsjö L. Lindahl A. Lundberg P.-A. Isaksson O.G.P. Lindstedt S. Bengtsson B.-Å. ( 1995) Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters. Neuroendocrinology, 61, 57 66.